Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Menicon CoFRA:5FR -1.63%89 Gross Margin % is 52.83% as of Mar. 2026, which is 1% below its 10-year median of 53.33. GuruFocus rates FRA:5FR with a GF Score™ of 89/100 and a GF Value™ of €9.01. The stock has 3 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Menicon Co ranks better than 52.98% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Menicon Co's Gross Profit for the
three
months ended in Mar. 2026 was €91.2 Mil. Menicon Co's Revenue for the
three
months ended in Mar. 2026 was €172.7 Mil. Therefore, Menicon Co's Gross Margin % for the quarter that ended in Mar. 2026 was 52.83%.
The historical rank and industry rank for Menicon Co's Gross Margin % or its related term are showing as below:
FRA:5FR'
s Gross Margin % Range Over the Past 10 Years
Min: 52.51 Med: 53.33 Max: 53.93
Current: 53.82
During the past 13 years, the highestGross Margin % of Menicon Co was 53.93%. The lowest was 52.51%. And the median was 53.33%.
FRA:5FR's Gross Margin % is ranked better than 52.98% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs FRA:5FR: 53.82
Menicon Co had a gross margin of 52.83% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Menicon Co was 0.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Menicon Co had a gross margin of 52.83% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Menicon Co Gross Margin % Related Terms
Menicon Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Menicon Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5FR vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Menicon Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Menicon Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Menicon Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Menicon Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Menicon Co (FRA:5FR) has a Gross Margin % of 52.83% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Menicon Co and its competitors. This is near median its historical median of 53.33. Over the past decade, Menicon Co's Gross Margin % has ranged from 52.51 to 53.93. According to the industry distribution chart, Menicon Co ranks #379 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 47%.
Is Menicon Co's Gross Margin % too high?
Menicon Co's current Gross Margin % of 52.83% is near median its 10-year median of 53.33. Over the past 10 years, this metric has ranged from a low of 52.51 to a high of 53.93. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Menicon Co's value of 52.83% is 1.4% above this industry median. Based on the distribution chart, Menicon Co ranks #379 out of 806 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Menicon Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Menicon Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Menicon Co ranks #379 out of 806 companies for Gross Margin %. This puts Menicon Co in the upper half of its industry. The industry median Gross Margin % is 52.12. Menicon Co's value of 52.83% is 1.4% above this benchmark. Historically, Menicon Co's own Gross Margin % has ranged from 52.51 to 53.93 over the past decade. While the company's 10-year median is 53.33 vs. the industry median of 52.12, Menicon Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Menicon Co's current Gross Margin % of 52.83% is 1.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Menicon Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Menicon Co's current Gross Margin % is 52.83%, which is near median its own 10-year median of 53.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Menicon Co stock overvalued right now?
Menicon Co (FRA:5FR) has a current Gross Margin % of 52.83%. The stock's GF Value™ is €9.01, compared to a current price of €9.05 — trading 0.4% above its estimated fair value. The current Gross Margin % is 52.83%, which is near median its 10-year median of 53.33 and 1.4% above the Medical Devices & Instruments industry median of 52.12. Menicon Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Menicon Co (FRA:5FR), the current Gross Margin % is 52.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Menicon Co (FRA:5FR) Overvalued in 2026?
Based on GuruFocus' analysis, Menicon Co stock appears to be overvalued.
The current stock price of €9.05 is trading 0.4% above its estimated GF Value™ of €9.01.
Key valuation signals for FRA:5FR:
Gross Margin %: 52.83% (near median its 10-year median of 53.33)
GF Value™: €9.01 vs. price of €9.05 (0.4% above fair value)
Industry Position: 1.4% above the Medical Devices & Instruments median (#379 of 806)
No single metric tells the full story. See the FRA:5FR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
89GF Score
Get the complete analysis for FRA:5FR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5FR has been successfully added to your 
